Harvey Capital Management Inc Acadia Pharmaceuticals Inc Transaction History

Harvey Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 07, 2018	SELL	$15.07 - $22.34 $3.3 Million - $4.89 Million	-219,042 Closed	0 $0
Q1 2018 Apr 27, 2018	BUY	$22.47 - $32.33 $4,494 - $6,466	200 Added 0.09%	219,042 $4.92 Million
Q4 2017 Feb 02, 2018	SELL	$26.84 - $39.14 $318,268 - $464,122	-11,858 Reduced 5.14%	218,842 $6.59 Million
Q3 2017 Nov 08, 2017	BUY	$29.49 - $38.37 $6.8 Million - $8.85 Million	230,700	230,700 $8.69 Million

348

163M

811K

334K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.3B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Harvey Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Harvey Capital Management Inc with notifications on news.